TELA Bio, Inc. (NASDAQ: TELA) reported Q1 EPS of ($0.25), $0.05 worse than the analyst estimate of ($0.20). Revenue for the quarter came in at $18.5 million versus the consensus estimate of $21.05 million.

For earnings history and earnings-related data on TELA Bio, Inc. (TELA) click here.